Furthermore, Fig. 8 demonstrates that KGEC can influence the activation of p38 and AP1 proteins downstream of the non-alcoholic fatty liver pathway, impacting the treatment of liver cirrhosis. This evidence concerns the gene JUN and cirrhosis of liver.